학술논문

Erdheim-Chester disease with novel gene mutations discovered as an incidental finding in explanted liver of a patient with hepatitis C cirrhosis: A case report and literature review
Document Type
article
Source
Pathology - Research and Practice. 212(9)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Chronic Liver Disease and Cirrhosis
Digestive Diseases
Human Genome
Hepatitis
Biotechnology
Liver Disease
Genetics
Clinical Research
Cancer
2.1 Biological and endogenous factors
Aetiology
Good Health and Well Being
Aged
DNA Mutational Analysis
Erdheim-Chester Disease
Hepatitis C
Hepatocyte Nuclear Factor 1-alpha
High-Throughput Nucleotide Sequencing
Humans
Incidental Findings
Liver
Liver Cirrhosis
Male
Mutation
PTEN Phosphohydrolase
Receptor
Platelet-Derived Growth Factor alpha
Erdheim-Chester disease
Histiocytosis
Cirrhosis
Liver transplant
Pathology
Clinical sciences
Oncology and carcinogenesis
Language
Abstract
Erdheim-Chester disease (ECD) is a rare form of non-Langerhans cell histiocytosis characterized by xanthogranulomatous infiltration of foamy histiocytes frequently involving bone and other organ systems. We herein report a unique case of ECD discovered incidentally in an explanted liver in a 65-year-old male with end-stage liver disease secondary to hepatitis C cirrhosis. Histological examination and immunohistochemical studies in the explanted liver revealed prominent foamy histiocytes that were CD68 positive, but CD1a and S100 negative. Mutational hotspot analysis of the explanted liver using a panel of 47 most common cancer-related genes performed by next generation sequencing (NGS) revealed likely somatic mutations in the PDGFRA, PTEN, and HNF1A genes, but no BRAF codon 600 mutations were detected. The bone marrow showed similar findings as in the liver. Whole body PET and bone scans demonstrated increased heterogeneous uptake in bilateral humeral and femoral diaphysis, most compatible with ECD. To our knowledge, this is the first case report of ECD that involves mainly bone marrow and liver with novel genomic alterations. Our case highlights the diversity and complexity of this disease entity and the importance of multi-modality approach integrating clinical and radiologic features with histopathologic and molecular/genomic findings.